- Trials with a EudraCT protocol (78)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
78 result(s) found for: ICP.
Displaying page 1 of 4.
EudraCT Number: 2009-012199-29 | Sponsor Protocol Number: 2080 | Start Date*: 2009-07-20 |
Sponsor Name:North Bristol NHS Trust Research and Development Office [...] | ||
Full Title: 8.4% sodium bicarbonate v 5% sodium chloride for raised intracranial pressure - a randomised controlled trial. | ||
Medical condition: Intracranial hypertension with coma after severe head injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004698-15 | Sponsor Protocol Number: S60859 | Start Date*: 2021-05-03 |
Sponsor Name:UZ Leuven / KU Leuven | ||
Full Title: Brain Injury and Ketamine: a prospective, randomized controlled double blind clinical trial to study the effects of ketamine on Therapy Intensity Level and intracranial pressure in acute brain inju... | ||
Medical condition: Traumatic Brain Injury patients requiring sedation to control the intracranial pressure (ICP). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004890-15 | Sponsor Protocol Number: EU-C-001-II-01 | Start Date*: 2019-06-05 | |||||||||||
Sponsor Name:Eustralis Pharmaceuticals Ltd. | |||||||||||||
Full Title: A double-blind placebo-controlled study with an open-label pilot phase, assessing the efficacy, tolerability and safety of EU-C-001 in patients with moderate to severe traumatic brain injury | |||||||||||||
Medical condition: Traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000280-17 | Sponsor Protocol Number: 17299425TRM2001 | Start Date*: 2007-06-28 |
Sponsor Name:Janssen-Cilag International N.V | ||
Full Title: An Open Label Single and Repeat Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-17299425 in Patients with Traumatic Brain Injury. | ||
Medical condition: Traumatic Brain Injury (TBI) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001863-35 | Sponsor Protocol Number: THAM | Start Date*: 2016-06-21 |
Sponsor Name:Universitätsklinik für Klinische Pharmakologie, Medizinische Universität Wien | ||
Full Title: Effects of Tromethamine on Cerebral Oxygenation and Metabolism in Patients Suffering Intractable Intracranial Hypertension – an exploratory study. | ||
Medical condition: Critically ill patients (SAH, ICB, AVM bleedings, malignant MCA infarcts) under sedation and mechanical ventilation in need of multimodality monitoring, including brain tissue oxygen monitoring and... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-005319-66 | Sponsor Protocol Number: 2005/W/AN/02 | Start Date*: 2006-06-02 |
Sponsor Name:Research and Development Office, Royal Infirmary of Edinburgh | ||
Full Title: A comparative study of HyperHAES (7.2% NACL and 6% hydroxyethyl starch) and 20% mannitol in the treatment of elevated intracranial pressure after brain injry | ||
Medical condition: elevated intracranial pressure after brain injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004011-44 | Sponsor Protocol Number: UofATURRIFIC | Start Date*: 2020-05-20 |
Sponsor Name:The University of Adelaide | ||
Full Title: A randomised trial of URsodeoxycholic acid versus RIFampicin in severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC study, comparing their effectiveness in the reduction of pruri... | ||
Medical condition: Intrahepatic Cholestasis of Pregnancy (ICP) is an serious liver condition in pregnancy. The main symptom of this is itching. Ursodeoxycholic acid is routinely used to treat cholestasis but is not... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Completed) GB (GB - no longer in EU/EEA) SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006694-39 | Sponsor Protocol Number: ASF-CP02-001 | Start Date*: 2022-07-08 | ||||||||||||||||
Sponsor Name:Lantmännen Medical AB | ||||||||||||||||||
Full Title: An open-label, historical cohort control study to evaluate the safety and tolerability of AF-16 in patients with cerebral oedema caused by traumatic brain injury (TBI) | ||||||||||||||||||
Medical condition: Cerebral oedema caused by traumatic brain injury (TBI) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004478-41 | Sponsor Protocol Number: LCC001 | Start Date*: 2015-03-10 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Phase III trial in IntrahepaTic CHolestasis of pregnancy (ICP) to Evaluate urSodeoxycholic acid (UDCA) in improving perinatal outcomes | |||||||||||||
Medical condition: Intrahepatic Cholestasis of pregnancy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000140-58 | Sponsor Protocol Number: NL7255100000 | Start Date*: 2020-07-23 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Complement Inhibition: Attacking the Overshooting Inflammation @fter Traumatic Brain Injury - A phase II trial on the safety and efficacy of C1 esterase inhibitor Cinryze for the acute management o... | |||||||||||||
Medical condition: Severe traumatic Brain Injury (TBI) with GCS < 13 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017256-27 | Sponsor Protocol Number: MUSICA-2 | Start Date*: 2010-04-05 |
Sponsor Name:Servicio de Cardiología. Hospital Universitario Vall d'Hebron | ||
Full Title: Ensayo de eficacia y seguridad de la doble antiagregación comparada con la combinación de anticoagulación oral + doble antiagregación en pacientes con fibrilación auricular de bajo-moderado riesgo ... | ||
Medical condition: Prevención de trombosis en pacientes con fibrilación auricular e implantación de stent coronario | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003907-11 | Sponsor Protocol Number: ICP-2007/00 | Start Date*: 2008-01-30 |
Sponsor Name:Grupo de Investigación ICP | ||
Full Title: Estudio aleatorizado, unicéntrico, que compara un régimen de dosis elevada de clopidogrel frente a la dosis estándar en pacientes diabéticos tipo 2 revascularizados mediante una estrategia invasiv... | ||
Medical condition: Síndrome coronario agudo (angina inestable / infarto agudo de miocardio sin elevación de ST) en combinación con Ácido Acetilsalicílico | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007127-40 | Sponsor Protocol Number: D1443L00048 | Start Date*: 2008-09-10 |
Sponsor Name:Astra ZenecaGmbH | ||
Full Title: CARE II - Evaluation of treatment outcomes in schizophrenic patients taking part in the integrated care program - a single-country, multi-centre phase IV study | ||
Medical condition: Symptomatic schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder or psychotic disorder not otherwise specified | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2009-012338-56 | Sponsor Protocol Number: VAS203/II/1/03 | Start Date*: 2009-07-10 | |||||||||||
Sponsor Name:vasopharm GmbH | |||||||||||||
Full Title: AN EXPLORATIVE PHASE IIa STUDY TO ASSESS SAFETY, TOLERABILITY, PHARMACODYNAMICS AND PHARMACOKINETICS OF VAS203 IN PATIENTS WITH MODERATE AND SEVERE TRAUMATIC BRAIN INJURY | |||||||||||||
Medical condition: Moderate and severe traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FR (Completed) ES (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000068-11 | Sponsor Protocol Number: SAVDEX-12 | Start Date*: 2012-05-16 |
Sponsor Name:Turku University Hospital | ||
Full Title: The effects of dexmedetomidine on cerebral autoregulation and cerebral oxygenation in subarachnoid haemorrhage patients. | ||
Medical condition: This study will be conducted on aneurysmal subarachnoid hemorrhage patients. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000219-14 | Sponsor Protocol Number: 1957 | Start Date*: 2008-03-19 | |||||||||||
Sponsor Name:North Bristol NHS Trust | |||||||||||||
Full Title: Efficacy of 8.4% sodium bicarbonate in adult patients with closed head injuries and intracranial hypertension. | |||||||||||||
Medical condition: Raised intracranial pressure after severe head injury. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008143-24 | Sponsor Protocol Number: gas alogenati | Start Date*: 2009-02-12 |
Sponsor Name:AZIENDA OSPEDALIERA SAN GERARDO DI MONZA | ||
Full Title: Inhalatorial sedation in patient with SAH versus conventional intravenus sedation | ||
Medical condition: sub-arachnoid haemorrage | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001542-17 | Sponsor Protocol Number: T109/2019Xe-SAH | Start Date*: 2020-09-17 | |||||||||||
Sponsor Name:Timo Laitio | |||||||||||||
Full Title: Effect of xenon on brain injury, neurological outcome and survival in patients after aneurysmal subarachnoid hemorrhage | |||||||||||||
Medical condition: Acute rupture of cerebral aneurysm, subarachnoid hemorrhage (SAH), unconsciousness, brain injury. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003310-24 | Sponsor Protocol Number: UDCAPSCSURV | Start Date*: 2015-10-09 |
Sponsor Name:Sahlgrenska Academy | ||
Full Title: A Phase 3, Open-label, Randomized, Prospective Clinical Trial Evaluating the Efficacy of Stratified Treatment with Ursodeoxycholic Acid (UDCA) in Preventing Hepatobiliary and Colorectal Malignancy ... | ||
Medical condition: Primary sclerosing cholangitis with or without concomitant inflammatory bowel disease included in an unlimited surveillance program for hepatobiliary and colorectal malignancy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-006752-14 | Sponsor Protocol Number: DualActionWeightLossinIIH1 | Start Date*: 2022-08-23 | |||||||||||
Sponsor Name:Rigshospitalet, Neurologisk afdeling | |||||||||||||
Full Title: Glucagone Like Peptide-1 Receptor (GLP-1R) Analogue Assisted Rapid Weight Loss Program as treatment of Idiopathic Intracranial Hypertension | |||||||||||||
Medical condition: Idiopathic Intracranial Hypertension (IIH) is a disease in which the intracranial pressure is pathologically elevated. This can cause blindness, chronic, severe headache, and cognitive dysfunction.... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
